Combination of Inhaled Corticosteroids and β2-Agonists in Asthma

Maureen P. M. H. Rutten-van Mölken; Huib A. M. Kerstjens

doi:10.1007/bf03259370

Combination of Inhaled Corticosteroids and β2-Agonists in Asthma

Clinical Immunotherapeutics ◽

10.1007/bf03259370 ◽

1996 ◽

Vol 6 (6) ◽

pp. 489-505 ◽

Cited By ~ 5

Author(s):

Maureen P. M. H. Rutten-van Mölken ◽

Huib A. M. Kerstjens

Keyword(s):

Inhaled Corticosteroids ◽

Β2 Agonists

Inhaled corticosteroids and long-acting β2-agonists in asthma and COPD treatment. Fluticasone propionate and salmeterol for long-term control of asthma and COPD

Medycyna Faktów ◽

10.24292/01.mf.0417.1 ◽

2017 ◽

Vol 10 (4) ◽

pp. 302-305

Author(s):

Andrzej Obojski

Keyword(s):

Fluticasone Propionate ◽

Inhaled Corticosteroids ◽

Long Acting ◽

Β2 Agonists

Potential side effects in patients treated with inhaled corticosteroids and long-acting β2-agonists

Respiratory Medicine ◽

10.1016/j.rmed.2008.10.028 ◽

2009 ◽

Vol 103 (4) ◽

pp. 566-573 ◽

Cited By ~ 5

Author(s):

J. Korsgaard ◽

M. Ledet

Keyword(s):

Side Effects ◽

Inhaled Corticosteroids ◽

Long Acting ◽

Β2 Agonists

Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial

The Lancet ◽

10.1016/s0140-6736(16)31324-1 ◽

2016 ◽

Vol 388 (10056) ◽

pp. 2115-2127 ◽

Cited By ~ 498

Author(s):

Eugene R Bleecker ◽

J Mark FitzGerald ◽

Pascal Chanez ◽

Alberto Papi ◽

Steven F Weinstein ◽

...

Keyword(s):

Severe Asthma ◽

Inhaled Corticosteroids ◽

Efficacy And Safety ◽

Phase 3 ◽

Long Acting ◽

Β2 Agonists

A Comparison of Short-Term Growth During Treatment with Two Dry Powder Combinations of Inhaled Corticosteroids and Long-Acting β2-Agonists

Journal of Aerosol Medicine and Pulmonary Drug Delivery ◽

10.1089/jamp.2014.1157 ◽

2015 ◽

Vol 28 (3) ◽

pp. 182-188

Author(s):

Ole D. Wolthers ◽

Tushar Shah

Keyword(s):

Inhaled Corticosteroids ◽

Dry Powder ◽

Short Term ◽

Long Acting ◽

Β2 Agonists

The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis

npj Primary Care Respiratory Medicine ◽

10.1038/s41533-017-0014-1 ◽

2017 ◽

Vol 27 (1) ◽

Cited By ~ 21

Author(s):

Ian D. Pavord ◽

Nicola Mathieson ◽

Anna Scowcroft ◽

Riccardo Pedersini ◽

Gina Isherwood ◽

...

Keyword(s):

United Kingdom ◽

Asthma Control ◽

Inhaled Corticosteroids ◽

Cross Sectional ◽

The United Kingdom ◽

Asthma Patients ◽

Long Acting ◽

Sectional Analysis ◽

The Impact ◽

Β2 Agonists

Therapeutic preferences and factors determining the use of inhaled corticosteroids with long-acting β2-agonists in patients with asthma and chronic obstructive pulmonary disease

Advances in Dermatology and Allergology ◽

10.5114/ada.2020.99945 ◽

2020 ◽

Author(s):

Magdalena Olszanecka-Glinianowicz ◽

Jerzy Chudek ◽

Agnieszka Almgren-Rachtan

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Inhaled Corticosteroids ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Long Acting ◽

Therapeutic Preferences ◽

Β2 Agonists

Intervention Studies of Inhaled Corticosteroids Combined with Long-acting Theophylline or Long-acting β2-agonists in Patients with Moderate to Severe Asthma: A Randomized, Controlled Study

Clinical Therapeutics ◽

10.1016/j.clinthera.2016.10.015 ◽

2016 ◽

Vol 38 (12) ◽

pp. 2622-2627.e1 ◽

Cited By ~ 1

Author(s):

Yan Wang ◽

Ping Chen ◽

Anna Dai ◽

Shengyun Shang ◽

Lingfei Kong

Keyword(s):

Severe Asthma ◽

Intervention Studies ◽

Inhaled Corticosteroids ◽

Randomized Controlled Study ◽

Controlled Study ◽

Randomized Controlled ◽

Long Acting ◽

Β2 Agonists

Inhaled Corticosteroids, Combined with Long-acting β2-Agonists, Improve the Perception of Bronchoconstriction in Asthma

American Journal of Respiratory and Critical Care Medicine ◽

10.1164/ajrccm.164.5.9910103 ◽

2001 ◽

Vol 164 (5) ◽

pp. 764-769 ◽

Cited By ~ 37

Author(s):

I. D. BIJL-HOFLAND ◽

S. G. M. CLOOSTERMAN ◽

H. Th. M. FOLGERING ◽

F. J. J. van den ELSHOUT ◽

C. van WEEL ◽

...

Keyword(s):

Inhaled Corticosteroids ◽

Long Acting ◽

Β2 Agonists

Patient-Reported Clinical Control and Peak-Flow: Effects of 30 Versus 6 Month Treatment with Inhaled Corticosteroids (ICS) with/without Long-Acting β2-Agonists (LABA) in Moderately Severe COPD.

10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a2923 ◽

2009 ◽

Cited By ~ 1

Author(s):

JB Snoeck-Stroband ◽

TS Lapperre ◽

MM Gosman ◽

WJ Assendelft ◽

HM Boezen ◽

...

Keyword(s):

Peak Flow ◽

Inhaled Corticosteroids ◽

Clinical Control ◽

Patient Reported ◽

Flow Effects ◽

Long Acting ◽

Β2 Agonists ◽

Severe Copd

Symptom control in patients with asthma using inhaled corticosteroids/long-acting β2-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort study

Journal of Asthma ◽

10.1080/02770903.2021.1963767 ◽

2021 ◽

pp. 1-14

Author(s):

Carlyne M. Averell ◽

François Laliberté ◽

Guillaume Germain ◽

Mei Sheng Duh ◽

Robson Lima ◽

...

Keyword(s):

Cohort Study ◽

Inhaled Corticosteroids ◽

Symptom Control ◽

Matched Cohort ◽

Fluticasone Furoate ◽

Matched Cohort Study ◽

The Us ◽

Long Acting ◽

Β2 Agonists